MktsMarkets

IDEXX Laboratories, Inc.
NASDAQ: IDXXKey statistics
IDXX News
Stories mentioning IDXX from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 1,140,820 | 1,090,579 | 1,105,239 | 1,109,457 | 998,427 | 954,288 | 975,543 | 1,003,578 |
| Cost of Goods Sold | 418,081 | 432,465 | 421,885 | 414,725 | 375,048 | 383,628 | 379,505 | 384,419 |
| Gross Profit | 722,739 | 658,114 | 683,354 | 694,732 | 623,379 | 570,660 | 596,038 | 619,159 |
| Operating Expenses | ||||||||
| Research & Development | 65,788 | 66,833 | 63,415 | 61,898 | 59,061 | 57,729 | 53,978 | 55,450 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 360,153 | 342,509 | 328,508 | 321,686 | 306,845 | 308,974 | 292,146 | 355,358 |
| Operating Income (Loss) | 362,586 | 315,605 | 354,846 | 373,046 | 316,534 | 261,686 | 303,892 | 263,801 |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | ||||||||
| Pretax Income | 355,442 | 306,982 | 344,771 | 362,352 | 310,084 | 256,387 | 298,909 | 259,056 |
| Tax Provision | 76,996 | 58,794 | 70,161 | 68,363 | 67,407 | 40,238 | 66,068 | 55,758 |
| Net Income (Loss) | 278,446 | 248,188 | 274,610 | 293,989 | 242,677 | 216,149 | 232,841 | 203,298 |
| Earnings Per Share (Basic) | 3.50 | 3.09 | 3.43 | 3.66 | 2.98 | 2.62 | 2.83 | 2.46 |
| Earnings Per Share (Diluted) | 3.47 | 3.06 | 3.40 | 3.63 | 2.96 | 2.60 | 2.80 | 2.44 |
| Weighted Average Shares Outstanding (Basic) | 79,648 | 80,427 | 80,096 | 80,413 | 81,319 | 82,467 | 82,304 | 82,630 |
| Weighted Average Shares Outstanding (Diluted) | 80,162 | 81,025 | 80,675 | 80,994 | 81,922 | 83,246 | 83,056 | 83,393 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About IDXX
IDEXX Laboratories, Inc. (NASDAQ: IDXX) is a stock listed on the Nasdaq Stock Market under the ticker symbol IDXX. It last traded at $676.04 (Nov 6, 2026, 4:00 PM ET), up 0.8% on the day. That gives IDEXX Laboratories a market capitalisation of $53.3B and a price-to-earnings ratio of 45.0.
Over the past 52 weeks IDXX has traded between $500.61 and $769.98.
Revenue for the quarter ended Mar 31, 2026 was $1.1B; net income $278.4M. Revenue was up 14.3% from $998.4M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $1.1B | $278.4M | 24.4% |
| Dec 31, 2025 | $1.1B | $248.2M | 22.8% |
| Sep 30, 2025 | $1.1B | $274.6M | 24.8% |
| Jun 30, 2025 | $1.1B | $294.0M | 26.5% |
From IDEXX Laboratories’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…